Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 12Radiation Injuries 3Glioma 3Glioblastoma 2Cognitive Dysfunction 2Astrocytoma 2Stroke 1Pituitary Neoplasms 1Parkinson Disease 1Oligodendroglioma 1Neurofibromatosis 1 1Neoplasm Metastasis 1Meningioma 1Medulloblastoma 1Infratentorial Neoplasms 1Fatigue 1

Interventions

Temozolomide 405Radiotherapy 202Bevacizumab 157Radiation 80Magnetic Resonance Spectroscopy 77Lomustine 49Surgical Procedures, Operative 45Carmustine 41pembrolizumab 40Irinotecan 38Nivolumab 32Specimen Handling 28Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Drug Therapy 23Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15Blood Specimen Collection 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13Ipilimumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × Neuropsychological Tests × CNS × Clear all
NCT01854554 2024-01-02

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

M.D. Anderson Cancer Center

Phase 2 Completed
90 enrolled 11 charts
CNS

Brain Neoplasms, Glioblastoma

NCT01711580 2015-05-12

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Maastricht Radiation Oncology

Withdrawn
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡